Comparative effectiveness of mepolizumab and omalizumab in patients eligible for both: a retrospective cohort study

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY · Published 2026-07-16 · DOI 10.1186/s13223-026-01055-9

Free full text

Authors (8)

Tatsuya Nagai, Naoki Inoshima, Hiroki Matsui, Norihiko Kubota, Yoshihiro Funaki, Ayumu Otsuki, Hiroyuki Ito, Kei Nakashima

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Nagai, T., Inoshima, N., Matsui, H., et al. (2026). Comparative effectiveness of mepolizumab and omalizumab in patients eligible for both: a retrospective cohort study. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY. https://doi.org/10.1186/s13223-026-01055-9

Related articles